CIBC Bancorp USA’s Cogent Biosciences COGT Stock Holding History
Bought
Maintained
Sold
Other funds holding COGT
CIBC Bancorp USA's COGT Position: Q3 2026 in Review
CIBC Bancorp USA increased its Cogent Biosciences (COGT) stake by 79% in Q3 2026, buying an estimated $269K and bringing the position to 16,487 shares worth $528K. The position accounts for ﹤0.01% of the portfolio, ranked #1342.
CIBC Bancorp USA first reported a position in COGT in Q3 2025 and has held it in 4 quarters since. 314 funds tracked by Wall St. Rank hold COGT as of Q3 2026.
- CIBC Bancorp USA held 16,487 shares of Cogent Biosciences worth $528K as of Q3 2026.
- CIBC Bancorp USA bought 7,279 Cogent Biosciences shares in Q3 2026, an estimated $269K.
- Cogent Biosciences made up ﹤0.01% of CIBC Bancorp USA's portfolio in Q3 2026, its #1342 holding.
- CIBC Bancorp USA first reported a position in Cogent Biosciences in Q3 2025 and has held it in 4 quarters since.
- 314 funds tracked by Wall St. Rank held Cogent Biosciences as of Q3 2026.
Based on CIBC Bancorp USA's 13F filing for Q3 2026, filed 13 Nov 2026.